GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » Return-on-Tangible-Equity

McKesson Europe AG (HAM:CLS1) Return-on-Tangible-Equity : -54.78% (As of Mar. 2022)


View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. McKesson Europe AG's annualized net income for the quarter that ended in Mar. 2022 was €-872 Mil. McKesson Europe AG's average shareholder tangible equity for the quarter that ended in Mar. 2022 was €1,592 Mil. Therefore, McKesson Europe AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2022 was -54.78%.

The historical rank and industry rank for McKesson Europe AG's Return-on-Tangible-Equity or its related term are showing as below:

HAM:CLS1's Return-on-Tangible-Equity is not ranked *
in the Medical Distribution industry.
Industry Median: 8.115
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

McKesson Europe AG Return-on-Tangible-Equity Historical Data

The historical data trend for McKesson Europe AG's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Return-on-Tangible-Equity Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.04 -5.51 -26.26 -1.19 -54.78

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.04 -5.51 -26.26 -1.19 -54.78

Competitive Comparison of McKesson Europe AG's Return-on-Tangible-Equity

For the Medical Distribution subindustry, McKesson Europe AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Return-on-Tangible-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Return-on-Tangible-Equity falls into.



McKesson Europe AG Return-on-Tangible-Equity Calculation

McKesson Europe AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2022 )  (A: Mar. 2021 )(A: Mar. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2022 )  (A: Mar. 2021 )(A: Mar. 2022 )
=-872.3/( (987.1+2197.6 )/ 2 )
=-872.3/1592.35
=-54.78 %

McKesson Europe AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2022 )  (Q: Mar. 2021 )(Q: Mar. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2022 )  (Q: Mar. 2021 )(Q: Mar. 2022 )
=-872.3/( (987.1+2197.6)/ 2 )
=-872.3/1592.35
=-54.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Mar. 2022) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


McKesson Europe AG  (HAM:CLS1) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


McKesson Europe AG Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (HAM:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines